Since its outbreak in December 2019, the COVID-19 pandemic has caused the death of
more than 6.5 million people around the world. The high transmissibility of its causative …

The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has called for an urgent need for dedicated antiviral therapeutics. Metal complexes are …

Coronaviruses constitute a significant threat to the human population. Severe acute
respiratory syndrome coronavirus-2, SARS-CoV-2, is a highly pathogenic human …

The COVID-19 pandemic caused by SARS-CoV-2 virus has created a global damage and
has exposed the vulnerable side of scientific research towards novel diseases. The intensity …

Abstract The Epstein–Barr virus (EBV) is widespread and has been related to a variety of
malignancies as well as infectious mononucleosis. Despite the lack of a vaccination …

To gain world-wide control over COVID-19 pandemic, it is necessary to have affordable and
accessible vaccine and monoclonal antibody technologies across the globe. In comparison …

Target recognition is important for the identification of drugs with a high target specificity
and/or for the development of existing drugs that could be replicated for the treatment of …

A Síndrome Respiratória Aguda Grave do Coronavírus 2 (SARS-CoV-2), o agente causador
da Covid-19, é um vírus de RNA de fita simples de sentido positivo, cujo processo …

The fast rate of viral mutations of SARS CoV-2 result in decrease in the efficacy of the
vaccines that have been developed before the emergence of these mutations. Thus, it is …

The rapid spread and infection rate of novel severe acute respiratory syndrome coronavirus
(SARS-CoV-2) has created a worldwide pandemic since its origin in 2019. Another concern …